Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $77.27M Sept. 30, 2015
Broadfin Capital 8.95M $51.20M Sept. 30, 2015
FMR 5.33M $30.50M Sept. 30, 2015
STATE STREET CORPORATION 4.50M $25.73M Sept. 30, 2015
Baker Bros. Advisors 4.35M $24.89M Sept. 30, 2015
Royce & Associates 2.98M $17.04M Sept. 30, 2015
BlackRock Fund Advisors 2.84M $16.25M Sept. 30, 2015
Tudor Investment Corporation 2.39M $13.68M Sept. 30, 2015
Vanguard 2.37M $14.55M Dec. 31, 2015
Millennium Management 2.28M $13.04M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 1.82M $10.43M Sept. 30, 2015
Wellington Management Company 1.65M $12.30M June 30, 2015
Highland Capital Management 1.59M $8.25M Sept. 30, 2014
Deerfield Management Company 1.35M $4.02M Dec. 31, 2012